Zymeworks Names Suzanne Monahan Commercial SVP and Theravance Biopharma General Manager

Bitget2026/10/19 10:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Zymeworks appointed Suzanne Monahan senior vice president, commercial and general manager, Theravance Biopharma, effective immediately.
Monahan will lead YUPELRI commercial strategy and execution following the acquisition of Theravance Biopharma.
She most recently served as senior vice president at Pacira BioSciences, overseeing multiple sales forces and strategic partnerships.
Her background includes more than 20 years of commercial leadership experience across pharmaceuticals and medical devices.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zymeworks Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610190600PRIMZONEFULLFEED9848068) on October 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Zymeworks Names Suzanne Monahan Commercial SVP and Theravance Biopharma General Manager

You may also like

Crypto prices